Moderna saysThe latest research results of its COVID-19 vaccine confirm that the vaccine can provide strong protection.
This is a week later(Developed in cooperation with its German partner BioNTech).
On Monday’s “CBS This Morning,” Secretary of Health and Human Services Alex Azar said that if approved, the vaccine could be available in the United States before Christmas, and the governor would decide who Be the first to adapt to receive them.
Azar said that after Pfizer applied for an emergency use authorization, the FDA announced that it would hold an advisory committee meeting on December 1
“Therefore, we may see both vaccines enter people’s arms before Christmas.”
Hazard told Tony Dokupil, co-host of “CBS This Morning,” the Centers for Disease Control and Prevention will make recommendations to prioritize the distribution of vaccines.
“At the CDC, we have an organization called the Advisory Committee on Immunization Practices (ACIP), and they have been meeting with us to advise who to give based on the data and case conditions we have obtained on these vaccines. National epidemiology-should we get vaccinated first?” Azar said. “This is still going on. I hope this week we can make them clearer from their advice and the CDC director’s perspective. But please consider the people in the most vulnerable nursing homes; consider those on the front line of medical work People. Most of the interactions occurred with suspicious COVID cases because we will be the first people to try to vaccinate.”
Dokoupil said: “The federal government will ship to the states, and then you say that the governor will have the final authority to vaccinate first.” “If you see at the federal level people skip rope because they have money or connections, what will prevent Does this happen?”
“Again, we will not ship vaccines to the states. I do want to be clear about this: We ship vaccines through the normal vaccine distribution system,” Azar replied. “Our governor is really like an air traffic controller. They will tell us which hospital they want to go to, which pharmacy, and where to go. They will determine which people to prioritize.
“I hope that the science and evidence are clear enough to enable our governor to follow the recommendations we made to them. Of course we will point out any unfairness or injustice we see in the method, and we will evaluate all of our select.
Azar said: “This afternoon I will talk to the vice president and all governors of the United States.” “I have confidence in our governor to do the right thing here.”
In light of the polls, Azar also discussed the government’s messaging strategyThey think it has not been fully tested.
Azar said: “We are doing a large-scale public affairs campaign. I hope we can broadcast it on the radio this week, and will broadcast it on TV shortly thereafter, to help people understand these vaccines.” “An interesting piece. The thing: We actually had to go back to the whiteboard of these campaigns, because the Moderna and Pfizer vaccines were so effective in these clinical trials, we actually had to make some modifications to consider our campaign materials.
“Then the most important thing we are doing is we keep politics out and make sure that everything is done through those independent checks in the system that you and I often talk about.”
Dokoupil asked: “Are they specifically targeting specific groups of people-people who think black and brown, people who are more vulnerable-are particularly suspicious of what is going through the federal process?”
He replied: “Yes, there is a specificity there, because as you know, the history related to certain clinical trial studies that happened in the past is very regrettable and regrettable.” “That’s why we are so focused, so focused To ensure that a large number of ethnic minority communities participate in these clinical trials, the latest Moderna data in the entire clinical trial today shows that I think 30% of the trials come from underserved communities, especially our African-American and Latino communities. Therefore, we have a very strong population participating in the study. I would like to say, as a secretary, thank all those who participated in these clinical trials. You really give us hope that because these reliable vaccines are coming now, they will be possible in the future.”
Dokoupil said: “You said you are doing a messaging activity; while you are engaged in logistics work, during the development process, the time to deliver the messaging activity will not be earlier than before. [vaccines]?
“Actually, Tony, no.” Hazard said. “First of all, we have to be very sensitive. The other party complained that if we were to carry out campaigns to educate people about vaccines before the election, people expressed a lot of concerns about this. We postponed these campaigns.
“But you also want to be right in time. You can’t determine the time for a market two months before the general vaccine is on the market. You just won’t play a role, so you want the vaccine to be really on time. Availability, so you really Have the call to action that will have the greatest impact.
He said: “The time has come.”
As of today, the United States has reported more than 13 million cases of the virus. More than 266,000 people died, and at least one American died of the coronavirus every minute.
4.2 million cases have been diagnosed in November, twice the number of the previous month.
In the United States, COVID-related hospitalizations have also reached an all-time high-close to 100,000, and officials have warned that this situation will soon get worse after Thanksgiving, which they call a “surge.”